Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
330.92
-4.69 (-1.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
41
42
Next >
Amgen's Stelara-Based Biosimilar Shows Comparable Efficacy, Safety Profile For Psoriasis
April 19, 2022
Via
Benzinga
Growth Is Struggling – Sunday, April 17
April 17, 2022
Growth stocks are struggling in 2022. This fact was apparent last week when I wrote about Buffett is Buying. However, this fact is not surprising.
Via
Talk Markets
Analyzing Amgen Inc's Short Interest
April 14, 2022
Amgen Inc's (NASDAQ:AMGN) short percent of float has fallen 8.14% since its last report. The company recently reported that it has 24.47 million shares sold short, which is 4.4%...
Via
Benzinga
AbbVie Stock Breaks Its Stride As Key Executive Departs For Flagship
April 13, 2022
Flagship Pioneering is swiping one of AbbVie's biggest names.
Via
Investor's Business Daily
Deciphera's DCC-3116/KRAS Inhibitor Combo Shows Deeper, Longer Tumor Regressions In Preclinical Studies
April 13, 2022
Deciphera Pharmaceuticals Inc (NASDAQ: DCPH)
Via
Benzinga
Where Amgen Stands With Analysts
April 12, 2022
Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter:
Via
Benzinga
Amgen's Lumakras Shows Two-Year Overall Survival Of 32.5% In KRAS-Mutated Lung Cancer
April 11, 2022
Via
Benzinga
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
April 12, 2022
Picture credit: Esteban Lopez on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Biomea Fusion Shares BMF-219 Preclinical Data At AACR 2022 Meeting
April 11, 2022
Biomea Fusion Inc (NASDAQ: BMEA)
Via
Benzinga
Buffett Is Buying
April 10, 2022
Warren Buffett has recently put the cash pile at Berkshire to work, buying stock and entire companies. So what exactly is Buffett buying and why?
Via
Talk Markets
Dividend Income Update March 2022
April 08, 2022
The start of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated.
Via
Talk Markets
$1000 Invested In Amgen 10 Years Ago Would Be Worth This Much
April 04, 2022
Amgen (NASDAQ:AMGN) has outperformed the market over the past 10 years by 1.13% on an annualized basis producing an average annual return of 13.98%. Currently, Amgen has a market capitalization of...
Via
Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
As these Chinese stocks face delisting, some may provide a contrarian play on improving relations between the U.S. and China.
Via
InvestorPlace
Looking Into Amgen Inc's Recent Short Interest
March 25, 2022
Amgen Inc's (NASDAQ:AMGN) short percent of float has risen 123.83% since its last report. The company recently reported that it has 26.62 million shares sold short, which is 4.79...
Via
Benzinga
Ten Healthcare Companies With High Payout Ratio
March 25, 2022
The healthcare industry is among the biggest U.S. market segments in terms of market capitalization, but when it comes to dividend payouts, they rank very low.
Via
Talk Markets
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much
March 15, 2022
Amgen (NASDAQ:AMGN) has outperformed the market over the past 10 years by 1.42% on an annualized basis. Buying $100 In AMGN: 10 years ago, an investor could have purchased 1.47...
Via
Benzinga
Best Biotech Stocks To Buy In 2022
March 15, 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and...
Via
Talk Markets
The Dow Curse
March 14, 2022
It has been 386 trading days since the last Dow changes were made at the end of August 2020. Below we show how the stocks added and removed performed in the 386 trading days leading up to the index...
Via
Talk Markets
Markets Fall Again As Russia-Ukraine War Erodes Investor Sentiment
March 11, 2022
U.S. Indices finished lower Friday amid continued uncertainty from the Russia-Ukraine conflict. The Nasdaq composite finished lower by 2.18% to 12,843; The Invesco QQQ Trust...
Via
Benzinga
Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why
March 09, 2022
Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside. Analyst...
Via
Benzinga
7 Dividend Stocks to Finance Your Golden Years
March 09, 2022
If you're a long-term investor you need top-quality dividend stocks in your portfolio. That doesn't mean big yields as much as reliable ones.
Via
InvestorPlace
AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar
March 09, 2022
Alvotech Holdings S.A. has entered into a settlement agreement with AbbVie Inc (NYSE: ABBV), allowing Alvotech to market AVT02 (100 mg/mL), its high-...
Via
Benzinga
Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study
March 08, 2022
Citing unanticipated delay in the collection of study data, Can-Fite BioPharma Ltd (NYSE: CANF) said that the topline data from its Phase 3 Comfort study of Piclidenoson...
Via
Benzinga
Markets Close Lower Again In Up And Down Trading Day; Nasdaq Falls 1.5%
March 03, 2022
U.S. indices had a mixed day of trading, with stocks experiencing continued volatility amid the Russia-Ukraine conflict. The conflict has continued...
Via
Benzinga
36 Stocks To Watch After Biden's First State of The Union Address
March 02, 2022
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped...
Via
Benzinga
Amgen's Tezspire Reduces Annualized Exacerbation Rate In Severe Asthma Patients
February 28, 2022
Amgen Inc (NASDAQ: AMGN) shared results from a pooled post-hoc analysis of the NAVIGATOR Phase 3 and PATHWAY Phase 2b trials of Tezspire (tezepelumab-ekko) in broad...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
A Bullish Sign Appears On Amgen's Chart
February 23, 2022
If history is any guide, there may be good fortune ahead for shares of Amgen (NASDAQ:AMGN). A so-called "golden cross" has formed on its chart and, not surprisingly, this could...
Via
Benzinga
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
41
42
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.